EPO Patents = 3

Trademarks = 2

Forward Citations = 2

Loading Chart...

7 inventors (with patents filed for the assignee):

Weidong Jiang (5 out of 5 patents)

Pei-Hua Lin (5 out of 6 patents)

Chi-Ling Tseng (4 out of 5 patents)

4. Ming Yang (1 out of 22 patents)

5. Wei-Dong Jiang (1 out of 1 patent)

6. Wenfeng Xu (1 out of 1 patent)

7. Jie Xue (1 out of 1 patent)

8. Wei-Dong Jiang (1 patent)

9. Chi-Ling Tseng (0 patent)

10. Pei-Hua Lin (0 patent)

11. Weidong Jiang (0 patent)

6 patents: Sort by Forward Citations

1. 12415858 - Anti-tigit antibodies, multispecific antibodies comprising the same, and methods of using the same (2025-09-16),

2. 11685783 - Anti-PD-1 antibodies (2023-06-27),

3. 11618786 - Anti-PD-L1 antibodies and variants (2023-04-04),

4. 11274155 - Anti-PD-L1 antibodies and variants (2022-03-15),

5. 11261255 - Anti-epidermal growth factor receptor (EGFR) antibodies (2022-03-01),

6. 11028173 - Anti-PD-1 antibodies (2021-06-08),

Shanghai Henlius Biotech Inc. is a leading biopharmaceutical company focusing on developing, manufacturing and commercializing high-quality and affordable biologic medicines. The company's mission is to provide accessible and innovative treatments for patients worldwide. Henlius is committed to advancing the field of biotechnology through cutting-edge research and development in the areas of oncology, autoimmune diseases, and other therapeutic areas.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

6 Patents

#339 in Shanghai

#3,900 in China

Shanghai, China

Shanghai Henlius Biotech Inc.